# OnCo record paper-patel-ivermectin-cancer-curr-oncol-rep-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-patel-ivermectin-cancer-curr-oncol-rep-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-patel-ivermectin-cancer-curr-oncol-rep-2025" ;
  schema:name "Ivermectin in cancer treatment: should healthcare providers caution or explore its therapeutic potential?"@en ;
  schema:description "A 2025 review that weighs the laboratory promise against the absence of human trials and concludes that clinicians should counter misinformation while supporting proper trials."@en ;
  schema:url <https://onco.cc/key-papers/paper-patel-ivermectin-cancer-curr-oncol-rep-2025/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1007/s11912-025-01704-z>, <https://pubmed.ncbi.nlm.nih.gov/40715995/> ;
  schema:sameAs <https://doi.org/10.1007/s11912-025-01704-z> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Patel Y, Chawla J, Parmar MS." ;
  onco:technologies <https://onco.cc/technologies/fenbendazole-ivermectin-repurposing-claims/> ;
  onco:drugs <https://onco.cc/drugs/ivermectin/> ;
  onco:terms <https://onco.cc/terms/preclinical/>, <https://onco.cc/terms/off-label/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-misinformation/> ;
  onco:journals <https://onco.cc/journals/current-oncology-reports/> .